These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16247480)

  • 1. Type I collagen is a molecular target for inhibition of angiogenesis by endogenous thrombospondin-1.
    Zhou L; Isenberg JS; Cao Z; Roberts DD
    Oncogene; 2006 Jan; 25(4):536-45. PubMed ID: 16247480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor.
    Isenberg JS; Calzada MJ; Zhou L; Guo N; Lawler J; Wang XQ; Frazier WA; Roberts DD
    Matrix Biol; 2005 Apr; 24(2):110-23. PubMed ID: 15890262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.
    Isenberg JS; Ridnour LA; Perruccio EM; Espey MG; Wink DA; Roberts DD
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13141-6. PubMed ID: 16150726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1.
    Ridnour LA; Isenberg JS; Espey MG; Thomas DD; Roberts DD; Wink DA
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13147-52. PubMed ID: 16141331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor.
    Rodriguez-Manzaneque JC; Lane TF; Ortega MA; Hynes RO; Lawler J; Iruela-Arispe ML
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12485-90. PubMed ID: 11606713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells.
    Guo N; Krutzsch HC; Inman JK; Roberts DD
    Cancer Res; 1997 May; 57(9):1735-42. PubMed ID: 9135017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced proangiogenic signaling in thrombospondin-1-deficient retinal endothelial cells.
    Wang Y; Wang S; Sheibani N
    Microvasc Res; 2006 May; 71(3):143-51. PubMed ID: 16624339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
    Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects.
    Filleur S; Volpert OV; Degeorges A; Voland C; Reiher F; Clézardin P; Bouck N; Cabon F
    Genes Dev; 2001 Jun; 15(11):1373-82. PubMed ID: 11390357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterization of novel thrombospondin 1 type I repeat fusion proteins.
    Qabar AN; Bullock J; Matej L; Polverini P
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):147-53. PubMed ID: 10657251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling.
    Sweetwyne MT; Pallero MA; Lu A; Van Duyn Graham L; Murphy-Ullrich JE
    Am J Pathol; 2010 Oct; 177(4):1710-24. PubMed ID: 20724603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
    Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
    Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-1, PECAM-1, and regulation of angiogenesis.
    Sheibani N; Frazier WA
    Histol Histopathol; 1999 Jan; 14(1):285-94. PubMed ID: 9987673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts.
    Frangogiannis NG; Ren G; Dewald O; Zymek P; Haudek S; Koerting A; Winkelmann K; Michael LH; Lawler J; Entman ML
    Circulation; 2005 Jun; 111(22):2935-42. PubMed ID: 15927970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin-1 and thrombospondin-2 mRNA and TSP-1 and TSP-2 protein expression in uterine fibroids and correlation to the genes COL1A1 and COL3A1 and to the collagen cross-link hydroxyproline.
    Behera MA; Feng L; Yonish B; Catherino W; Jung SH; Leppert P
    Reprod Sci; 2007 Dec; 14(8 Suppl):63-76. PubMed ID: 18089612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of polyamines and increase of transforming growth factor-beta1, c-myc, collagen-type I, matrix metalloproteinase-1, and metalloproteinase-2 mRNA in primary human gingival fibroblasts.
    Stabellini G; Moscheni C; Gagliano N; Dellavia C; Calastrini C; Ferioli ME; Gioia M
    J Periodontol; 2005 Mar; 76(3):443-9. PubMed ID: 15857080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization.
    Ueno A; Miwa Y; Miyoshi K; Horiguchi T; Inoue H; Ruspita I; Abe K; Yamashita K; Hayashi E; Noma T
    J Cell Physiol; 2006 Nov; 209(2):322-32. PubMed ID: 16883596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the three-dimensional organization of thyroid epithelial cells into follicle structures by the matricellular protein, thrombospondin-1.
    Pellerin S; Croizet K; Rabilloud R; Feige JJ; Rousset B
    Endocrinology; 1999 Mar; 140(3):1094-103. PubMed ID: 10067831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
    Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
    Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.